Listed below is a summary of 2022, 2023, and 2024 highlights for IDSA guidelines as well as guidelines endorsed by IDSA.
Guideline |
Publication Date |
Journal |
---|---|---|
Guidelines Released in 2024 |
||
Primary Care Guidance Update (Joint with HIVMA) | 10/2024 | Clinical Infectious Diseases |
COVID:19 Treatment and Management (Focused Guideline Update: Pemivibart) | 8/2024 | IDSA & Clinical Infectious Diseases |
Antimicrobial Resistance Update | 7/2024 | IDSA & Clinical Infectious Diseases |
Intra-abdominal Infections (Multi-Part Series: Part 1) | 6/2024 | IDSA & Clinical Infectious Diseases |
Lab ID Guidance (Joint with ASM) | 3/2024 | Clinical Infectious Diseases |
Updates to COVID-19 guidelines: |
2/2024 |
IDSA & Clinical Infectious Diseases |
Guidelines Released in 2023 |
||
Bone and Joint Infections: Acute Bacterial Arthritis in Pediatrics | 11/2023 | IDSA & Pediatric Infectious Diseases Society |
New Fever in Critically Ill Patients | 11/2023 | IDSA & Society of Critical Care Medicine |
Diabetic Foot Infections | 10/2023 | Clinical Infectious Diseases & Diabetes/Metabolism Research and Reviews |
Antimicrobial Resistance Update | 6/2023 | IDSA & Clinical Infectious Diseases |
Compendia on Catheter-Associated Urinary Tract Infections | 6/2023 | Infection Control & Hospital Epidemiology |
5/2023 | IDSA & Clinical Infectious Diseases | |
SHEA/IDSA/APIC Compendia Updates: |
||
Prevent Healthcare-Associated Infections Through Hand Hygiene |
2/2023 |
Infection Control & Infectious Diseases
|
4/2023 |
||
5/2023 |
||
6/2023 |
||
Updates to COVID-19 Guidelines: |
||
6/2023 |
IDSA & Clinical Infectious Diseases |
|
1/2023 |
||
9/2023 |
||
Guidelines Released in 2022 |
||
Updated Guidance on Antimicrobial-Resistant Gram-Negative Infections, v1.1: ESBL-E, CRE, and Pseudomonas aeruginosa with Difficult-to-Treat Resistance | 3/2022 | IDSA & Clinical Infectious Diseases |
Updates to COVID-19 Guidelines: | ||
Treatment and Management | 9/2022 | IDSA & Clinical Infectious Diseases |
Diagnostics: Antigen Testing | 12/2022 | |
SHEA/IDSA/APIC Compendia Updates: |
||
Central Line-associated Bloodstream Infections | 4/2022 | Infection Control & Hospital Epidemiology |
Ventilator-associated Pneumonia, Ventilator-associated Events, and Nonventilator Hospital-acquired Pneumonia | 5/2022 |
Listed below is a summary of IDSA guidelines in development and topics prioritized for future development.
Guideline |
Publication Date (Estimated) |
Journal |
---|---|---|
Guidelines in Development |
||
Antimicrobial Prophylaxis in Surgery (Joint with ASHP/SHEA/SIS) | 2024, Q4 | American Journal of Health-System Pharmacy |
Aspergillosis (Multi-Part Series) | 2025, Q1 (Part 1) | Clinical Infectious Diseases |
Community-Acquired Pneumonia in Adults (Joint with ATS) | 2025, Q2 | American Journal of Respiratory and Critical Care Medicine |
Community-Acquired Pneumonia in Children (Joint with PIDS) | 2025, Q1 | Clinical Infectious Diseases |
Diagnosis and Management of HAP/VAP (Joint with ATS) | 2025, Q4 | Clinical Infectious Diseases |
Drug-Susceptible and Drug-Resistant Tuberculosis (Joint with ATS/ERS/CDC) | 2025, Q2 | American Journal of Respiratory and Critical Care Medicine |
HBV (Joint with AASLD) | 2024, Q4 | Hepatology |
HCV (Joint with AASLD) | 2024, Q4 | Hepatology |
Histoplasmosis (Multi-Part Series) | 2024, Q4 (Part 1) | Clinical Infectious Diseases |
Immunomodulators | 2025, Q1 | Clinical Infectious Diseases |
IV Catheter | 2024, Q4 | Clinical Infectious Diseases |
Staphylococcus aureus Bacteremia (Joint with ESCMID) (Multi-Part Series) | 2024, Q4 | Clinical Infectious Diseases |
Strep Pharyngitis (Multi-Part Series) | 2024, Q4 (Part 1) | Clinical Infectious Diseases |
Treatment of Uncomplicated Urinary Tract Infections (Multi-Part Series) | 2024, Q4 (Part 1) | Clinical Infectious Diseases |
Updates to COVID-19 Guidelines: Treatment and Management |
Ongoing | IDSA & Clinical Infectious Diseases |
Guidelines Prioritized for Development |
||
Diagnosis and Management of Prosthetic Joint Infections | TBD | TBD |
Diagnosis and Management of Skin and Soft Tissue Infections | TBD | TBD |
Management of Enterococcal Infections (including Vancomycin-Resistant Enterococcus) (NEW TOPIC) | TBD | TBD |